The Many Faces of Expanded Dengue Syndrome: A Two-Case Series of Renal and Hepatic–Neurological Organ Involvement in Adult Patients
Abstract
Introduction: The rising global incidence of dengue has been accompanied by increasing recognition of atypical, organ-dominant presentations collectively termed expanded dengue syndrome (EDS), in which severe involvement of the liver, kidney, heart, lung or central nervous system dominates the clinical picture and drives mortality. We describe two adult men who illustrate contrasting EDS phenotypes.
Case presentation: Case I, a 30-year-old man with serologically confirmed secondary dengue infection (IgM-negative, IgG-positive), presented with gross haematuria, dysuria and warning signs and developed acute kidney injury (oliguria, rising creatinine, proteinuria, marked erythrocyturia) superimposed on leucopenia, severe thrombocytopenia and haemoconcentration; he recovered fully with carefully titrated crystalloid and renoprotective measures. Case II, a 23-year-old man with a primary infection, deteriorated on the sixth day with agitated delirium and acute liver failure (transaminases exceeding 100 times the upper limit, hyperbilirubinaemia, coagulopathy, hypoalbuminaemia) complicated by hepatic encephalopathy; he improved with supportive care, electrolyte correction and multidisciplinary management.
Conclusion: EDS may arise from either secondary or primary infection, and organ dysfunction tends to resolve in step with the natural history of dengue. Meticulous fluid stewardship stratified by clinical group, with systematic evaluation for intensive-care needs using clinical,…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.